Transporter-Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate

Izna Ali, Jason R. Slizgi, Josh D. Kaullen, Marija Ivanovic, Mikko Niemi, Paul W. Stewart, Alfred S. Barritt, Kim L. R. Brouwer

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Volume104
Issue number4
Pages (from-to)749-756
Number of pages8
ISSN0009-9236
DOIs
Publication statusPublished - Oct 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • FATTY LIVER-DISEASE
  • DUBIN-JOHNSON-SYNDROME
  • NONALCOHOLIC STEATOHEPATITIS
  • HEPATOBILIARY TRANSPORT
  • DRUG DISPOSITION
  • OUTCOMES
  • ACID
  • PHARMACOGENOMICS
  • TRANSPLANTATION
  • GLYCOSYLATION
  • 3111 Biomedicine
  • 317 Pharmacy

Cite this